These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7113181)

  • 1. [Clinical observations on the therapeutic activity of the preparation mendiaxon in diseases of the biliary tract].
    Ivanov S; Matinheva R; Kostova N
    Vutr Boles; 1982; 21(3):17-21. PubMed ID: 7113181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of Mendiakson in diseases of bile tract (author's transl)].
    Gabryelewicz A; Bajko K
    Przegl Lek; 1978; 35(11):815-7. PubMed ID: 734149
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of cantabiline on Oddi's sphincter].
    Chevrel B
    Med Chir Dig; 1979; 8(1):91-5. PubMed ID: 470485
    [No Abstract]   [Full Text] [Related]  

  • 4. [Odeston in treatment of chronic diseases of hepatobiliary system].
    Nasonova SV; Lebedeva OI
    Voen Med Zh; 2001 Feb; 322(2):49-53. PubMed ID: 11338822
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hymecromone in the treatment of symptoms following surgery of the bile ducts].
    Camarri E; Marchettini G
    Recenti Prog Med; 1988 May; 79(5):198-202. PubMed ID: 3051197
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of methylumbilliferone (mendiaxon r)-induced choleresis in the isolated perfused rat liver.
    Kroker R; Anwer MS; Hegner D
    Acta Hepatogastroenterol (Stuttg); 1977 Oct; 24(5):348-54. PubMed ID: 930535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The chologenic and choleretic action of sorbitol].
    Grancharov V
    Vopr Pitan; 1973; 32(2):50-4. PubMed ID: 4782923
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hymecromone in diseases of the bile ducts].
    Gehlhoff H; Semler P
    MMW Munch Med Wochenschr; 1978 May; 120(21):741-2. PubMed ID: 306555
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of cholagogic agents in the therapy of patients with dysfunction of the bile-secreting system].
    Nogaller AM; Barkhanova AG; Zakharova GIu
    Klin Med (Mosk); 1989 Sep; 67(9):129-35. PubMed ID: 2685457
    [No Abstract]   [Full Text] [Related]  

  • 10. [Imecromone: a new choleretic with antispastic action on Oddi's sphincter. Clinical pharmacology and clinico-statistical study].
    Cremoncini C; Tominz L
    Minerva Med; 1968 Oct; 59(82):4359-68. PubMed ID: 5683717
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experiences with the amphocholereticum Oddibil].
    Zawodsky L
    Wien Med Wochenschr; 1974 Nov; 124(46):677-80. PubMed ID: 4617977
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the potency of action of several choleretics].
    Mörsdorf K; Wolf G
    Dtsch Med J; 1966 May; 17(10):303-6. PubMed ID: 5985421
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the effect of 4-methyl-umbelliferon (Hymecromone) in patients following surgical revision of the biliary pathways].
    Walter P; Seidel W
    Chirurg; 1979 Jul; 50(7):436-40. PubMed ID: 477470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
    Marchettini G; Maggi P; Benvenuti C
    Clin Ter; 1978 Sep; 86(5):485-94. PubMed ID: 367683
    [No Abstract]   [Full Text] [Related]  

  • 15. Bile acid-independent bile flow is differently regulated by glucagon and secretin in humans after orthotopic liver transplantation.
    Lenzen R; Elster J; Behrend C; Hampel KE; Bechstein WO; Neuhaus P
    Hepatology; 1997 Nov; 26(5):1272-81. PubMed ID: 9362372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hymecromone in the treatment of motor disorders of the bile ducts: a multicenter, double-blind, placebo-controlled clinical study.
    Abate A; Dimartino V; Spina P; Costa PL; Lombardo C; Santini A; Del Piano M; Alimonti P
    Drugs Exp Clin Res; 2001; 27(5-6):223-31. PubMed ID: 11951580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lyobil--a new therapeutic preparation].
    Rafes IuI; Kryshen' PF; Bereza NM; Sheleketina II; Mnushkin EG
    Klin Med (Mosk); 1977; 55(1):78-82. PubMed ID: 839701
    [No Abstract]   [Full Text] [Related]  

  • 18. Palliative percutaneous transhepatic gallbladder drainage of gallbladder empyema before laparoscopic cholecystectomy.
    Tseng LJ; Tsai CC; Mo LR; Lin RC; Kuo JY; Chang KK; Jao YT
    Hepatogastroenterology; 2000; 47(34):932-6. PubMed ID: 11020851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Double-blind clinical study on hymecromone and placebo in motor disorders of the bile ducts after cholecystectomy].
    Quaranta S; Rossetti S; Camarri E
    Clin Ter; 1984 Mar; 108(6):513-7. PubMed ID: 6233070
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with a new spasmo-choleretic].
    Meissner O; Quitzow G
    Wien Med Wochenschr; 1966 Oct; 116(40):816-8. PubMed ID: 5925778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.